S. Rantapaa-Dahlqvist

Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work?

M. Neovius, C. Turesson, M. Englund, 2017, Annals of the rheumatic diseases.

Fine-mapping identifies causal variants for RA and T1D in DNASE1L3, SIRPG, MEG3, TNFAIP3 and CD28/CTLA4 loci

Annette Lee, P. Gregersen, J. Todd, 2017, bioRxiv.

The type I interferon signature as biomarker of pre-clinical Rheumatoid Arthritis

D. Schaardenburg, C. Verweij, S. Rantapaa-Dahlqvist, 2013 .

Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes.

A. Lefvert, S. Rantapaa-Dahlqvist, S. Wållberg-Jonsson, 2002, The Journal of rheumatology.

Fine-mapping and functional studies highlight potential causal variants for rheumatoid arthritis and type 1 diabetes

Annette Lee, P. Gregersen, J. Todd, 2018, Nature Genetics.

Fine-mapping and functional studies highlight potential causal variants for rheumatoid arthritis and type 1 diabetes

Annette Lee, P. Gregersen, J. Todd, 2018, Nature Genetics.

The Regulation of FasL Expression—A Distinguishing Feature Between Monocytes and T Lymphocytes/NK Cells with Possible Implications for SLE

S. Rantapaa-Dahlqvist, K. Sundqvist, A. Uddhammar, 2001, Journal of Clinical Immunology.

Plasminogen activator inhibitor and von Willebrand factor in polymyalgia rheumatica

T. Nilsson, S. Rantapaa-Dahlqvist, A. Uddhammar, 1992, Clinical Rheumatology.